Placebo Topical Solution: Clinical Trials

5 trials of Placebo Topical Solution, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting, 1 completed, 1 terminated. 4 Phase 3, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Not yet recruiting 2, Completed 1, Terminated 1
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow Placebo Topical Solution: new trials by email Literature Review of Placebo Topical Solution trials Research Report on Placebo Topical Solution

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)
CS-002, Placebo Topical Solution - Canities, Grey Hair
Phase 1 / Phase 2Not yet recruitingApplied Biology, Inc.1002025-10-012025-09-10
Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)
CS-001, Placebo Topical Solution - Canities, Grey Hair
Phase 3Not yet recruitingApplied Biology, Inc.2402025-06-152024-12-24
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
DA-005, Topical minoxidil 5%, DA-002 - Androgenetic Alopecia, Female Pattern Baldness
Phase 3Not yet recruitingApplied Biology, Inc.5162025-01-152024-12-19
Topical Application of Cocaine HCl 4%, or 10%, or Placebo Solution in Local (Topical) Anesthesia
Cocaine HCl 4% Topical Solution, Cocaine HCl 10% Topical Solution, Placebo Topical Solution - Any Ear Nose or Throat Conditions, With Identified Need for a Diagnostic Procedure or Surgery on or Through the Mucous Membranes of the Nasal Cavities
Phase 3CompletedLannett Company, Inc.6462015-09-012017-05-16
Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia
Cocaine HCl 4% Topical Solution, Cocaine HCl 10% Topical Solution, Placebo Topical Solution - Diagnostic, Procedures and Surgeries on or Through Accessible Mucous Membranes
Phase 3TerminatedLannett Company, Inc.1592014-03-012017-05-12

Conditions studied

Alopecia (1)  ·  Disease (1)

Sponsors

Applied Biology, Inc. (3)  ·  Lannett Company, Inc. (2)

Countries

United States (2)

Top investigators

Andy Goren, MD (1)